Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,441 | Dovepress* | 11,189+ | 1,736 | 12,925 | |
PubMed Central* | 1,252 | 487 | 1,739 | ||
Totals | 12,441 | 2,223 | 14,664 | ||
*Since 16 March 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar